2026 Updates on the Prevention of Respiratory Syncytial Virus (RSV) Infection (31 min.)
In this presentation, Dr. Jonathan Levin discusses guidance around the respiratory syncytial virus (RSV) vaccine and updates to prevention guidelines. He discusses the history of the RSV vaccine, use of the maternal vaccine as well as use for infants, and data surrounding insurance coverage and uptake. This presentation was recorded at Pediatric Asthma & Allergy Updates for Primary Care Providers on March 13, 2026.
$50.00
Description
Jonathan Levin, MD, MBIDirector, Center for Healthy Infant Lung Development, Boston Children’s Hospital
Learning Objectives:
At the conclusion of this educational program, learners will be able to:
- Review the history and challenges of RSV vaccine development
- Discuss the evidence and indications for the maternal RSV vaccine
- Discuss the evidence and indications for nirsevimab and clesrovimab (anti-RSV mAb)
- Evaluate real world efficacy and uptake of nirsevimab
- Review implementation challenges in 2026 and updated guidance
In support of improving patient care, Boston Children’s Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician
Boston Children’s Hospital designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.
Nurse
Boston Children’s Hospital designates this activity for 0.75 contact hours for nurses. Nurses should only claim credit commensurate with the extent of their participation in the activity.
MOC II
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn:
0.75 MOC points in the American Board of Pediatrics (ABP) Maintenance of Certification (MOC) program
Disclosure Policy
Boston Children’s Hospital adheres to all ACCME Essential Areas, Standards, and Policies. It is Boston Children’s policy that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that Boston Children’s may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.
Disclosure Statement
The following planners, speakers, and content reviewers, on behalf of themselves, have reported the following relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on patients:
Jonathan Levin, MD, MBI: None
Kenan Haver, MD: Royalties, UpToDate
Additional information
| Credit Type | ABP MOC Part II (Pediatrician), AMA PRA Category 1 Credits™ (MD, DO, NP, PA), Contact Hours (Nurse, Nurse Practitioner) |
|---|---|
| Duration | |
| Format | |
| Topic | Preventative Pediatrics/Well-Child Care, Family Medicine, General Pediatrics, Infectious disease, Primary Care, Pulmonary/Respiratory Disease |
| Expiration Date | |
| Release Date |
